Biotech · Private company
Rainier Therapeutics
Track this companyFree. Adds Rainier Therapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- B-701Phase 2 · Locally Advanced or Metastatic Urothelial Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- DocetaxelPhase 2 · Locally Advanced or Metastatic Urothelial Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- PembrolizumabPhase 2 · Locally Advanced or Metastatic Urothelial Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- VofatamabPhase 2 · Locally Advanced or Metastatic Urothelial Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- A Study of B-701 in Combination With Pembrolizumab in Treatment of Locally Advanced or Metastatic Urothelial Cell CarcinomaPHASE1_PHASE2 · TERMINATED · started Apr 20, 2017ClinicalTrials.gov NCT03123055 · fetched Nov 12, 2026
- Dose Escalation, Expansion Study of Vofatamab (B-701) in Treatment of Locally Advanced or Metastatic Urothelial Cell CarcinomaPHASE1_PHASE2 · TERMINATED · started Jun 1, 2015ClinicalTrials.gov NCT02401542 · fetched Nov 12, 2026